Bevacizumab, a monoclonal antibody to vascular endothelial growth factor (VEGF), and irinotecan for treatment of malignant gliomas.
Conference Paper
Full Text
Duke Authors
Cited Authors
- Vredenburgh, JJ; Desjardins, A; II, HJE; Quinn, J; Rich, J; Sathornsumetee, S; Friedman, HS; Reardon, D; Gururangan, S; Friedman, A
Published Date
- June 20, 2006
Published In
Volume / Issue
- 24 / 18
Start / End Page
- 59S - 59S
International Standard Serial Number (ISSN)
- 0732-183X